期刊文献+

血管紧张素Ⅱ和血管紧张素1-7对内皮细胞释放组织纤溶酶原激活物及其抑制剂-1的影响 被引量:3

The effects of angiotensinⅡand angiotensin-(1-7) on thesecretion of t-PA and PAI-1 in endothelial cells
原文传递
导出
摘要 目的 :研究血管紧张素Ⅱ (AngⅡ )和血管紧张素 1 7[Ang ( 1 7) ]对内皮细胞分泌组织纤溶酶原激活物 (t PA)和纤溶酶原激活物抑制剂 1(PAI 1)的影响。方法 :培养内皮细胞株 (ECV30 4 ) ,分为AngⅡ和Ang ( 1 7)刺激组 ,培养基中AngⅡ和Ang ( 1 7)加至终浓度为 5、10、2 5、5 0、10 0nmol/L ,2 4h后测定上清液中的t PA和PAI 1的含量。结果 :内皮细胞在AngⅡ终浓度为 5 0、10 0nmol/L组刺激 2 4h后 ,其分泌的PAI 1含量较对照组有明显升高 ,差异有统计学意义 (P <0 .0 5 )。而Ang ( 1 7)在同样浓度组却显著降低PAI 1(P <0 .0 5 ) ,AngⅡ和Ang ( 1 7)两组t PA含量差异无统计学意义 ( P >0 .0 5 )。结论 :AngⅡ对内皮细胞株分泌的PAI 1有显著的升高作用 ,而Ang ( 1 7)对PAI 1作用相反。两者对t PA均无显著影响。提示AngⅡ和Ang ( 1 7) Objective:To investigate the effects of angiotensinⅡ(AngⅡ)and angiotensin (1 7)[Ang (1 7)] on the secretion of t PA and PAI 1 in eddothetial cells..Methods:Cultivated ECV 304 cells were stimulated with AngⅡ(5,10,25,50,100 nmol/L)and Ang (1 7)(5,10,25,50,100 nmol/L) for 24 hours. Tissue type plasminogen activator (t PA) and plasminogen activator inhibitor 1(PAI 1) in the supernatant of the cell culture were measured by enzyme linked immunosorbent assay(ELISA).Results:The concentrations of t PA had no statistically significant changes whether the ECV304 cells were stimulated by AngⅡor Ang (1 7) .But PAI 1 was significantly increased by AngⅡ(50、100nmol/L)and decreased by Ang (1 7) at the same concentration.Conclusion:AngⅡand Ang (1 7) has no effects on t PA released from ECV304.But, PAI 1 can be increased by AngⅡ and decreased by Ang (1 7) . AngⅡor Ang (1 7) may play a important role in the regulation of fibrinolysis.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2004年第2期99-101,共3页 Journal of Clinical Cardiology
关键词 血管紧张素Ⅱ 血管紧张素1-7 内皮血管 组织纤溶酶原激活物 纤溶酶原激活物抑制剂-1 AngiotensinⅡ Angiotensin (1 7) Endothelium, vascular Tissue plasminogen activator Plasminogen activator inhibitor 1
  • 相关文献

参考文献9

  • 1[1]van Mourik J A, Lawrence D A, Loskutoff D J. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. J Biol Chem, 1984, 259:14914-14921.
  • 2[2]Diep Q N, E I Mabrouk M, Cohn J S, et al. Structure endothelial function, Cell growth, and inflammation in blood vessels of angiotensin Ⅱ-infused rats: Role of peroxisome proliferator-activated receptor-gamm.Circulation, 2002, 105: 2296-2302.
  • 3[3]Gibbons G H. The pathophsiology of hypertension: The importance of angiotensin Ⅱ in cardiovascular remodeling. Am J Hypertens, 1998, 11:177S-181S.
  • 4[4]Moriguchi A, Tallant E A, Matsumura K,et al.Opposing actions of Ang-(1-7) and angiotensin Ⅱ in the brain of transgenic hypertensive rats. Hypertension, 1995, 25:1260-1265.
  • 5[5]Nishimura H, Tsuji H, Masuda H, et al. Angiotensin Ⅱ increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of Tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells. Thromb Haemostasis, 1997, 77:1989-1995.
  • 6[6]Ridker P M,Gaboury C L,Conlin P R, et al. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin Ⅱ. Evidence of a potential interaction between the rennin-angiotensin system and fibrinolytic function. Circulation, 1993, 87:1969-1973.
  • 7[7]Yoshida M, Naito Y, Urana T, et al. L-158,809 and (D-Ala(7))-angiotensinⅠ/Ⅱ (1-7) decrease PAI-1 release from human umbilical vein endothelial cells. Thrombosis Res, 2002, 105:531-536.
  • 8[8]Erdem Y, Usalan C, Haznedaroglu I C, et al. Effects of angiotensin converting enzyme and angiotensin Ⅱ receptor inhibition on impaired fibrinolysis in systemic hypertension. Am J Hypertens, 1999,12:1071-1076 .
  • 9[9]Iyer S N, Ferrario C M, Chappell M C. Angiotensin- (1-7) contributes to the antihypertensive effects of blockade of the rennin-angiotensin system. Hypertension, 1998,31:356-361.

同被引文献25

  • 1郭颂然,马虹,何建桂.血管紧张素-(1-7)对异丙肾上腺素所致大鼠急性心肌缺血的保护作用[J].中山大学学报(医学科学版),2004,25(4):326-329. 被引量:3
  • 2王文艳,王兴祥,陈君柱.血管紧张素1-7与心血管疾病的关系[J].国外医学(心血管疾病分册),2004,31(4):214-216. 被引量:1
  • 3Renta D.Paula,Celso V.Lima,Raquel R.Potentiation of hypotensive effect of bradykin;n by angiotensin(1-7)-related peptides[J].Regulatory Peptides,1999,(20):493-500.
  • 4Beril T,Andreas D.Jan Danser A.H.Bradykinin,angiotensin(1-7)and ACE inhibitor:how do they interact?[J].IJBCB,2003,(35):792-801.
  • 5Mariela MG,Irene Y,Susana G.Angiotensin-(1-7)inhibits the angiotensin Ⅱ-enhanecd norepineph rine release in coarcted hypertensive rats[J].Regulatory Peptides,2004,(118):45-49.
  • 6De Souza AM,Lopes AG,Pizzino CP.Angiotensin Ⅱ and angiotensin-(1-7)inhibit the inner cortex Na+-ATPase activity through AT2 receptor[J].Regulatory Peptides.2004,(120):167-175.
  • 7Paula RD,Lima CV,Khosla MC.Angiotensin-(1-7)potentiates the hypotensive effect of bradykinin in conscious rats[J].hypertension,1995,26(2):1154-1159.
  • 8Robson AS,Santos MJ,Angiotensin-(1-7):an update[J].Regulatory Peptides,2000,(91):45-62.
  • 9Touyz RM,Schiffrin EL.Signal transductoin mechanisms mediating the physiological and pathophysiological actions of angiotensin Ⅱ in vascular smooth muscle cells[J].Pharmacol Rev,2000,(52):639-672.
  • 10Brosnihan KB,Lip Ferrario CM.Angiotensin-(1-7)dilates coronary arteries through kinins and nitricoxide[J].hypertension,1996,(27):523-528.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部